277 related articles for article (PubMed ID: 11253594)
21. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
[TBL] [Abstract][Full Text] [Related]
22. Combined modality therapy for stage III non-small cell lung cancer.
Stinchcombe TE; Fried D; Morris DE; Socinski MA
Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
[TBL] [Abstract][Full Text] [Related]
23. Combined-modality treatment of non-small-cell lung cancer stages I-III (take home messages).
Rübe C; Fleckenstein J
Lung Cancer; 2004 Aug; 45 Suppl 2():S139-41. PubMed ID: 15552794
[TBL] [Abstract][Full Text] [Related]
24. Which patients with stage III non-small cell lung cancer should undergo surgical resection?
Patel V; Shrager JB
Oncologist; 2005 May; 10(5):335-44. PubMed ID: 15851792
[TBL] [Abstract][Full Text] [Related]
25. Postrecurrence survival in patients with stage I non-small cell lung cancer.
Nakagawa T; Okumura N; Ohata K; Igai H; Matsuoka T; Kameyama K
Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404
[TBL] [Abstract][Full Text] [Related]
26. Imaging of non-small cell lung cancer.
Munden RF; Bruzzi J
Radiol Clin North Am; 2005 May; 43(3):467-80, vii. PubMed ID: 15847811
[TBL] [Abstract][Full Text] [Related]
27. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.
Oh Y; Taylor S; Bekele BN; Debnam JM; Allen PK; Suki D; Sawaya R; Komaki R; Stewart DJ; Karp DD
Cancer; 2009 Jul; 115(13):2930-8. PubMed ID: 19441110
[TBL] [Abstract][Full Text] [Related]
28. Complete resection of non-small-cell lung cancer and oligo-metastatic brain disease.
Daniels M; Wright GM
ANZ J Surg; 2005 Nov; 75(11):963-6. PubMed ID: 16336388
[TBL] [Abstract][Full Text] [Related]
29. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
30. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
Van Meerbeeck JP; De Pauw R; Tournoy K
Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
[TBL] [Abstract][Full Text] [Related]
31. Complex and controversial issues in locally advanced non-small cell lung carcinoma.
Machtay M; Jeremic B
Semin Surg Oncol; 2003; 21(2):128-37. PubMed ID: 14508863
[TBL] [Abstract][Full Text] [Related]
32. [Non-small cell lung cancer with oligometastases: treatment with curative intent].
Bonnette P
Cancer Radiother; 2012 Sep; 16(5-6):344-7. PubMed ID: 22921976
[TBL] [Abstract][Full Text] [Related]
33. Long-term survivors in stage IV non-small cell lung cancer.
Okamoto T; Maruyama R; Shoji F; Asoh H; Ikeda J; Miyamoto T; Nakamura T; Miyake T; Ichinose Y
Lung Cancer; 2005 Jan; 47(1):85-91. PubMed ID: 15603858
[TBL] [Abstract][Full Text] [Related]
34. [Long-term survival following multimodality treatment of metachronous metastases (parotid gland, adrenal gland, brain and mediastinal lymph node) after resection of non-small cell lung cancer; report of a case].
Katsurago N; Shiraishi Y; Hashizume M; Miyasaka Y
Kyobu Geka; 2006 Feb; 59(2):168-71. PubMed ID: 16482916
[TBL] [Abstract][Full Text] [Related]
35. [Locally advanced and metastatic non-small-cell lung cancer: towards a new optimal therapeutic strategy].
Fournel P
Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S8-15. PubMed ID: 15211226
[No Abstract] [Full Text] [Related]
36. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
Koukourakis M
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
[No Abstract] [Full Text] [Related]
37. [Treatment of non-resectable stage III non-small cell lung cancer].
Fournel P
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S43-7. PubMed ID: 15536352
[TBL] [Abstract][Full Text] [Related]
38. Metastatic non-small cell lung cancer: costs associated with disease progression.
Fox KM; Brooks JM; Kim J
Am J Manag Care; 2008 Sep; 14(9):565-71. PubMed ID: 18778171
[TBL] [Abstract][Full Text] [Related]
39. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
van Meerbeeck JP; Surmont VF
Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
[TBL] [Abstract][Full Text] [Related]
40. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
